The Impact of Long-term Pessary Use on Pelvic Organ Prolapse oìduring Covid-19 Pandemic in Patients Attending Surgery
1 other identifier
observational
200
1 country
1
Brief Summary
Patients aged 45 to 80 years with a clinical diagnosis of stage III and IV genital prolapse involving the anterior and/or middle compartments and candidates for surgery will be considered. These will be evaluated to observe whether there is improvement in clinical prolapse with the use of the vaginal pessary during the waiting period for surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2024
CompletedFirst Posted
Study publicly available on registry
January 31, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMay 21, 2024
May 1, 2024
1.7 years
January 25, 2024
May 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
evaluate a change in POPQ points on examination at the time of surgery from baseline evaluation.
Primary endopoint is the evaluation of the percentage of women who experience a change in any POPQ point on examination at the time of surgery from baseline evaluation.
At the time of surgery procedure, after at least 6 months after pessary placement
Interventions
use of vaginal pessary for patients waiting for gynecological surgery for stage III and IV pelvic organ prolapse
Eligibility Criteria
Women with symptomatic and documented POP (stages III and IV) through POPQ examination who opted for reconstructive surgery and managed with pessary until surgery will be included in the cohort.
You may qualify if:
- Pelvic organ prolapse with POP-Q stage \>/= 3 in anterior and/or central compartments
- Women between 45 and 80 years old
You may not qualify if:
- Women who refuse to participate in the study
- Patients without baseline POPQ examination documented or with a pessary previously positioned
- Previous pelvic surgeries
- Women with any contraindication for surgery or preference for conservative treatment only (pelvic muscle exercise, vaginal pessary)
- Women who are not successfully fitted with pessaries
- Current genital ulcers/infections
- Active or chronic pelvic infection
- Women who are mentally incapable of completing the questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS San Raffaele Hospital
Milan, 20132, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 25, 2024
First Posted
January 31, 2024
Study Start
July 1, 2024
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
May 21, 2024
Record last verified: 2024-05